Skip to main content
SLS
NASDAQ Life Sciences

SELLAS REGAL Trial Shows Stronger Survival Trends; Pre-BLA FDA Meeting Planned

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$8.18
Mkt Cap
$1.511B
52W Low
$1.39
52W High
$9.1
52W Position info
488% above low
Off High info
10% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SLS has more than doubled off its 52-week low of $1.39.

Summary

SELLAS Life Sciences' CEO announced that the pivotal Phase 3 REGAL trial is exhibiting stronger-than-expected survival trends. The company plans to hold a pre-BLA FDA meeting and potentially file for approval. This follows the May 12th 10-Q and 8-K filings, which indicated the REGAL trial was nearing final data analysis. Positive survival trends in a late-stage trial are highly material for a biotech company, signaling a significant step towards potential drug approval and commercialization. The planned pre-BLA meeting underscores the company's confidence in the data.

At the time of this announcement, SLS was trading at $8.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $1.39 to $9.10. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

SLS - Latest Insights

SLS
Nov 18, 2026, 10:00 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $17.98
Real-time Price: $15.00 info
Change: -$2.98 (-17%) info
Market Cap: $3.029B info
SLS
Nov 18, 2026, 12:03 AM EST
Source: CNBC TV18
Importance Score:
7
Price at Filing: $17.14
Real-time Price: $15.00 info
Change: -$2.14 (-12%) info
Market Cap: $3.029B info
SLS
Nov 17, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.03
Real-time Price: $15.00 info
Change: -$3.03 (-17%) info
Market Cap: $3.029B info
SLS
Nov 17, 2026, 10:09 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $20.45
Real-time Price: $15.00 info
Change: -$5.45 (-27%) info
Market Cap: $3.029B info
SLS
Nov 17, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
10
Price at Filing: $8.00
Real-time Price: $15.00 info
Change: +$7.00 (+88%) info
Market Cap: $3.029B info